The methicillin-resistant Staphylococcus aureus (MRSA) therapeutics market across the seven major pharmaceutical markets (7MM ...

Danish pharma major Novo Nordisk today announced first results from the STEP Young Phase III trial, evaluating once-weekly ...

Swedish biotech SynAct Pharma today announced results from a post-hoc analysis of the Phase IIb ADVANCE study evaluating ...

US biotech Stoke Therapeutics (Nasdaq: STOK) and USA-based biotech major Biogen (Nasdaq: BIIB) have set out long-term results ...

CNS specialist NeuShen Therapeutics, a biotech with research and development centers in Shanghai, China and Boston, Massachusetts, has closed an oversubscribed Series B financing round exceeding $80 ...

Japanese pharma major Shionogi today announced that it has received marketing authorization from the Therapeutic Goods ...

Medicines regulators in major international markets have issued a mix of first-in-class approvals, safety reviews, supply and shortage measures, consultations and one authorization suspension over the ...

Pharma trade group Innovative Medicines Canada (IMC) welcomes Deloitte Canada’s report showing the innovative pharmaceutical industry is a strategically important sector for Canada’s economic growth ...

New figures show that prices for prescription pharmacy medicines have never been lower in Denmark. At the same time, the ...

Last week’s significant news included BioMarin’s announcement of a settlement with Denmark’s Ascendis Pharma relating to ...

AstraZeneca’s Etcamah (camizestrant) in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor (abemaciclib, ...

Following the US Food and Drug Administration's (FDA) approval of Bixlenvo (bictegravir 75mg/lenacapavir 50mg)—the smallest ...